Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the domain of hematological malignancies. Novel treatment modalities such as targeted drugs, immunotherapies, and gene editing are altering the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering hope for more curative treatment o